The perceived effects of smoked cannabis on patients with multiple sclerosis

P Consroe, R Musty, J Rein, W Tillery, Roger Guy Pertwee

Research output: Contribution to journalArticle

248 Citations (Scopus)

Abstract

Fifty-three UK and 59 USA people with multiple sclerosis (MS) answered anonymously the first questionnaire on cannabis use and MS, From 97 to 30% of the subjects reported cannabis improved (in descending rank order): spasticity, chronic pain of extremities, acute paroxysmal phenomenon, tremor, emotional dysfunction, anorexia/weight loss, fatigue states, double vision, sexual dysfunction, bowel and bladder dysfunctions, vision dimness, dysfunctions of walking and balance, and memory loss. The MS subjects surveyed have specific therapeutic reasons for smoking cannabis. The survey findings will aid in the design of a clinical trial of cannabis or cannabinoid administration to MS patients or to other patients with similar signs or symptoms.

Original languageEnglish
Pages (from-to)44-48
Number of pages5
JournalEuropean Journal of Neurology
Volume38
Issue number1
DOIs
Publication statusPublished - 1997

Keywords

  • cannabis
  • marijuana
  • multiple sclerosis
  • neurological disorder
  • spasticity
  • pain
  • tremor
  • depression
  • USA patients with MS
  • UK patients with MS

Cite this

The perceived effects of smoked cannabis on patients with multiple sclerosis. / Consroe, P ; Musty, R ; Rein, J ; Tillery, W ; Pertwee, Roger Guy.

In: European Journal of Neurology, Vol. 38, No. 1, 1997, p. 44-48.

Research output: Contribution to journalArticle

Consroe, P ; Musty, R ; Rein, J ; Tillery, W ; Pertwee, Roger Guy. / The perceived effects of smoked cannabis on patients with multiple sclerosis. In: European Journal of Neurology. 1997 ; Vol. 38, No. 1. pp. 44-48.
@article{d1732d7dacce468e8740d43e9b07efc9,
title = "The perceived effects of smoked cannabis on patients with multiple sclerosis",
abstract = "Fifty-three UK and 59 USA people with multiple sclerosis (MS) answered anonymously the first questionnaire on cannabis use and MS, From 97 to 30{\%} of the subjects reported cannabis improved (in descending rank order): spasticity, chronic pain of extremities, acute paroxysmal phenomenon, tremor, emotional dysfunction, anorexia/weight loss, fatigue states, double vision, sexual dysfunction, bowel and bladder dysfunctions, vision dimness, dysfunctions of walking and balance, and memory loss. The MS subjects surveyed have specific therapeutic reasons for smoking cannabis. The survey findings will aid in the design of a clinical trial of cannabis or cannabinoid administration to MS patients or to other patients with similar signs or symptoms.",
keywords = "cannabis, marijuana, multiple sclerosis, neurological disorder, spasticity, pain, tremor, depression, USA patients with MS, UK patients with MS",
author = "P Consroe and R Musty and J Rein and W Tillery and Pertwee, {Roger Guy}",
year = "1997",
doi = "10.1159/000112901",
language = "English",
volume = "38",
pages = "44--48",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The perceived effects of smoked cannabis on patients with multiple sclerosis

AU - Consroe, P

AU - Musty, R

AU - Rein, J

AU - Tillery, W

AU - Pertwee, Roger Guy

PY - 1997

Y1 - 1997

N2 - Fifty-three UK and 59 USA people with multiple sclerosis (MS) answered anonymously the first questionnaire on cannabis use and MS, From 97 to 30% of the subjects reported cannabis improved (in descending rank order): spasticity, chronic pain of extremities, acute paroxysmal phenomenon, tremor, emotional dysfunction, anorexia/weight loss, fatigue states, double vision, sexual dysfunction, bowel and bladder dysfunctions, vision dimness, dysfunctions of walking and balance, and memory loss. The MS subjects surveyed have specific therapeutic reasons for smoking cannabis. The survey findings will aid in the design of a clinical trial of cannabis or cannabinoid administration to MS patients or to other patients with similar signs or symptoms.

AB - Fifty-three UK and 59 USA people with multiple sclerosis (MS) answered anonymously the first questionnaire on cannabis use and MS, From 97 to 30% of the subjects reported cannabis improved (in descending rank order): spasticity, chronic pain of extremities, acute paroxysmal phenomenon, tremor, emotional dysfunction, anorexia/weight loss, fatigue states, double vision, sexual dysfunction, bowel and bladder dysfunctions, vision dimness, dysfunctions of walking and balance, and memory loss. The MS subjects surveyed have specific therapeutic reasons for smoking cannabis. The survey findings will aid in the design of a clinical trial of cannabis or cannabinoid administration to MS patients or to other patients with similar signs or symptoms.

KW - cannabis

KW - marijuana

KW - multiple sclerosis

KW - neurological disorder

KW - spasticity

KW - pain

KW - tremor

KW - depression

KW - USA patients with MS

KW - UK patients with MS

U2 - 10.1159/000112901

DO - 10.1159/000112901

M3 - Article

VL - 38

SP - 44

EP - 48

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 1

ER -